세양

비상장계속사업자

SaeYang MicroTech Co.,Ltd.

신정필

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

세양

Business Reg. No. 5038168677 · CEO 신정필

I.Investment Overview

Target세양 (5038168677)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명세양
영문명SaeYang MicroTech Co.,Ltd.
대표자신정필
사업자등록번호5038168677
법인등록번호1701110292839
설립일2005.08.09

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW300.42021387.42022443.420233192024351.12025
영업이익100M KRW23.4202167.2202288.9202342.9202438.72025
순이익100M KRW27.9202154.9202271.6202333.6202431.22025
Item20252024202320222021
자산총계550.9억원528.5억원553.4억원511억원442.1억원
부채총계247.8억원248.6억원297.5억원313.9억원287.4억원
자본총계303.1억원279.9억원255.9억원197.1억원154.7억원
매출액351.1억원319억원443.4억원387.4억원300.4억원
영업이익38.7억원42.9억원88.9억원67.2억원23.4억원
순이익31.2억원33.6억원71.6억원54.9억원27.9억원

VI.Financial Ratios

FY2025 basis

11.01%

영업이익률

8.89%

순이익률

5.67%

ROA

10.3%

ROE

81.75%

부채비율

55.02%

자기자본비율

VII.R&D Activity

Fields 보건의료 > 치의과학 · 보건의료

Keywords 핸드피스, 모터, 센서리스, 틀니, 카트리지

YearProjectsPapersPatents
2023001
2021002
2020102
2019102
2018102
2017123
2016182
2015303
2014269
2013235
2012201
2011130
2010100

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

세양 투심보고서 | Alpha Lenz